Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

thyroid gland mucoepidermoid carcinoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent international multicenter study provides insights into the prognostic stratification of brain metastases from nonanaplastic follicular cell-derived thyroid carcinoma. The findings may enhance understanding of disease progression and treatment strategies.

A recent study published in PubMed highlights the clinicopathologic and molecular characteristics of poorly differentiated thyroid carcinomas in adults aged 45 and younger. This research may provide insights into the unique features of this aggressive cancer subtype.

A recent study published on PubMed presents a 3-case series demonstrating the efficacy of Yttrium-90 radioembolization in treating metastatic thyroid carcinoma to the liver. This research adds to the understanding of potential therapeutic options for this challenging condition.

Not rare diseases news,news about your rare disease.

Earlier

A recent international multicenter study provides insights into the prognostic stratification of brain metastases from nonanaplastic follicular cell-derived thyroid carcinoma. The findings may enhance understanding of disease progression and treatment strategies.

A recent study published in PubMed highlights the clinicopathologic and molecular characteristics of poorly differentiated thyroid carcinomas in adults aged 45 and younger. This research may provide insights into the unique features of this aggressive cancer subtype.

A recent study published on PubMed presents a 3-case series demonstrating the efficacy of Yttrium-90 radioembolization in treating metastatic thyroid carcinoma to the liver. This research adds to the understanding of potential therapeutic options for this challenging condition.

Not rare diseases news,
news about your rare disease.